Dupilumab reduces exacerbations independent of changes in biomarkers in moderate-to-severe asthma
Key words
fractional exhaled nitric oxide
eosinophils
lung function
exacerbations
Abbreviations usedAER
Annualized severe exacerbation rate
FeNO
Fractional exhaled nitric oxide
FEV1
Forced expiratory volume in 1 s
ICS
Inhaled corticosteroid
© 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
留言 (0)